The Angelina Jolie effect: Contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer

被引:23
作者
Basu, Narendra Nath [1 ,2 ]
Hodson, James [2 ]
Chatterjee, Shaunak [2 ]
Gandhi, Ashu [3 ]
Wisely, Julie [3 ]
Harvey, James [3 ]
Highton, Lyndsey [3 ]
Murphy, John [3 ]
Barnes, Nicola [3 ]
Johnson, Richard [3 ]
Barr, Lester [3 ]
Kirwan, Cliona C. [3 ]
Howell, Sacha [3 ,4 ]
Baildam, Andrew D. [3 ]
Howell, Anthony [3 ,4 ]
Evans, D. Gareth [3 ,4 ,5 ,6 ,7 ]
机构
[1] Univ Birmingham, Birmingham B15 2TT, W Midlands, England
[2] Univ Hosp Birmingham NHS Trust, Mindelsohn Way, Birmingham B15 2TH, W Midlands, England
[3] Manchester Univ NHS Fdn Trust, Wythenshawe Hosp, Prevent Breast Canc Res Unit, Manchester M23 9LT, Lancs, England
[4] Christie Hosp, Manchester Breast Ctr, Manchester M20, Lancs, England
[5] Manchester Univ Hosp NHS Fdn Trust, Manchester Ctr Genom Med, NW Genom Lab Hub, Manchester M13 9WL, Lancs, England
[6] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Evolut & Genom Sci,Sch Biol Sci, Manchester, Lancs, England
[7] Manchester Univ Hosp NHS Fdn Trust, Manchester Ctr Genom Med, Clin Genet Serv, Manchester M13 9WL, Lancs, England
关键词
D O I
10.1038/s41598-021-82654-x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Contralateral risk-reducing mastectomy (CRRM) rates have tripled over the last 2 decades. Reasons for this are multi-factorial, with those harbouring a pathogenic variant in the BRCA1/2 gene having the greatest survival benefit. On May 14th, 2013, Angelina Jolie shared the news of her bilateral risk-reducing mastectomy (BRRM), on the basis of her BRCA1 pathogenic variant status. We evaluated the impact of this news on rates of CRRM in women with increased risk for developing breast cancer after being diagnosed with unilateral breast cancer. The prospective cohort study included all women with at least a moderate lifetime risk of developing breast cancer who attended our family history clinic (1987-2019) and were subsequently diagnosed with unilateral breast cancer. Rates of CRRM were then compared between patients diagnosed with breast cancer before and after Angelina Jolie's announcement (pre- vs. post-AJ). Of 386 breast cancer patients, with a mean age at diagnosis of 48 +/- 8 years, 268 (69.4%) were diagnosed in the pre-AJ period, and 118 (30.6%) in the post-AJ period. Of these, 123 (31.9%) underwent CRRM, a median 42 (interquartile range: 11-54) days after the index cancer surgery. Rates of CRRM doubled following AJ's news, from 23.9% pre-AJ to 50.0% post AJ (p<0.001). Rates of CRRM were found to decrease with increasing age at breast cancer (p<0.001) and tumour TNM stage (p=0.040), and to increase with the estimated lifetime risk of breast cancer (p<0.001) and tumour grade (p=0.015) on univariable analysis. After adjusting for these factors, the step-change increase in CRRM rates post-AJ remained significant (odds ratio: 9.61, p<0.001). The AJ effect appears to have been associated with higher rates of CRRM amongst breast cancer patients with increased cancer risk. CRRM rates were highest amongst younger women and those with the highest lifetime risk profile. Clinicians need to be aware of how media news can impact on the delivery of cancer related services. Communicating objective assessment of risk is important when counselling women on the merits of risk-reducing surgery.
引用
收藏
页数:10
相关论文
共 43 条
  • [11] Ellis I., 2016, Poverty and mental health: A review to inform the Joseph Rowntree Foundation's Anti-poverty Strategy, P1
  • [12] Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer
    Elsayegh, Nisreen
    Webster, Rachel D.
    Barrera, Angelica M. Gutierrez
    Lin, Heather
    Kuerer, Henry M.
    Litton, Jennifer K.
    Bedrosian, Isabelle
    Arun, Banu K.
    [J]. CANCER MEDICINE, 2018, 7 (06): : 2718 - 2726
  • [13] Evans D.G., 2016, Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study
  • [14] Longer term effects of the Angelina Jolie effect: increased risk-reducing mastectomy rates in BRCA carriers and other high-risk women
    Evans, D. Gareth
    Wisely, Julie
    Clancy, Tara
    Lalloo, Fiona
    Wilson, Mary
    Johnson, Richard
    Duncan, Jonathon
    Barr, Lester
    Gandhi, Ashu
    Howell, Anthony
    [J]. BREAST CANCER RESEARCH, 2015, 17
  • [15] GUIDELINES Familial breast cancer: summary of updated NICE guidance
    Evans, D. Gareth
    Graham, John
    O'Connell, Susan
    Arnold, Stephanie
    Fitzsimmons, Deborah
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [16] The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services
    Evans, D. Gareth R.
    Barwell, Julian
    Eccles, Diana M.
    Collins, Amanda
    Izatt, Louise
    Jacobs, Chris
    Donaldson, Alan
    Brady, Angela F.
    Cuthbert, Andrew
    Harrison, Rachel
    Thomas, Sue
    Howell, Anthony
    Miedzybrodzka, Zosia
    Murray, Alex
    [J]. BREAST CANCER RESEARCH, 2014, 16 (05):
  • [17] Breast cancer risk assessment in 8,824 women attending a family history evaluation and screening programme
    Evans, D. Gareth R.
    Ingham, Sarah
    Dawe, Sarah
    Roberts, L.
    Lalloo, F.
    Brentnall, A. R.
    Stavrinos, P.
    Howell, Anthony
    [J]. FAMILIAL CANCER, 2014, 13 (02) : 189 - 196
  • [18] Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer
    Evans, D. Gareth R.
    Ingham, Sarah L.
    Baildam, Andrew
    Ross, Gary L.
    Lalloo, Fiona
    Buchan, Iain
    Howell, Anthony
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 140 (01) : 135 - 142
  • [19] Increasing rates of contralateral prophylactic mastectomy - A trend made in USA?
    Gueth, U.
    Myrick, M. E.
    Viehl, C. T.
    Weber, W. P.
    Lardi, A. M.
    Schmid, S. M.
    [J]. EJSO, 2012, 38 (04): : 296 - 301
  • [20] Improved overall survival after contralateral risk-reducing mastectomy in brca1/2 mutation carriers with a history of unilateral breast cancer: A prospective analysis
    Heemskerk-Gerritsen, Bernadette A. M.
    Rookus, Matti A.
    Aalfs, Cora M.
    Ausems, Margreet G. E. M.
    Collee, Johanna M.
    Jansen, Liesbeth
    Kets, C. Marleen
    Keymeulen, Kristien B. M. I.
    Koppert, Linetta B.
    Meijers-Heijboer, Hanne E. J.
    Mooij, Thea M.
    Tollenaar, Rob A. E. M.
    Vasen, Hans F. A.
    Hooning, Maartje J.
    Seynaeve, Caroline
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (03) : 668 - 677